Welcome to the AMANET Homepage.

The mission of AMANET is to "Promote Capacity Strengthening and Networking
of Malaria Research and Development in Africa"

Latest News and Events:

Call for Applications: Advanced Health Research Ethics Workshop for Investigators
AMANET Annual Report 2007
Vacancy: Project Manager, Multilateral Initiative on Malaria (MIM) Secretariat. Deadline 29 February 2008
AMANET Newsletter, issue 22
Press Release : Clinical Trial of Candidate Malaria Vaccine MSP3-LSP Launched in Tanga, Tanzania
Press Release: AMANET Announces Launch of Clinical Study of Candidate Malaria Vaccine GMZ2 in Gabon
Call for letters of intent: Afro-immunoassay Network
Press Release: Makerere University Receives a US$ 386,000 Grant for Capacity Strengthening in Malaria Research from AMANET
AMANET Strategic Plan 2007-2011
Press Release: AMANET Launches Clinical Trial of Candidate Malaria Vaccine AMA1 in Mali

AMANET in brief:

The African Malaria Network Trust [AMANET] started its activities as African Malaria Vaccine Testing Network [AMVTN] in 1995 with the primary goal of preparing Africa in planning and conducting malaria vaccine trials. However, due to expanding goals in malaria interventions, AMVTN was succeeded by AMANET in 2002 to reflect a widened scope that incorporates a broad and integrated approach in the fight against malaria.

The expanded role include among others; creation of global awareness of the African malaria burden, advancement of essential human capacity for research and development of malaria intervention in Africa, determination of the needs and characterisation of potential sites for testing malaria interventions in Africa and promotion of good governance, efficient management and networking of malaria institutions in Africa.

The African Malaria Network Trust [AMANET]
Tanzania Commission for Science and Technology Building
P.O. Box 33207,Dar es Salaam, Tanzania
Tel: 255 (022) 2700018, Fax: 255 (022) 2700380
General Email: info@amanet-trust.org